Verastem Inc (NASDAQ: VSTM)’s stock price has plunge by 8.33relation to previous closing price of 3.60. Nevertheless, the company has seen a -0.51% plunge in its stock price over the last five trading sessions. businesswire.com reported 2024-10-31 that BOSTON–(BUSINESS WIRE)–Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced that its management team will participate in the following upcoming investor conferences: 2024 Truist Securities BioPharma Symposium on November 7, 2024 Guggenheim Healthcare Innovation Conference; fireside chat on Wednesday, November 13, 2024 at 9:00 am EDT A live webcast of the fireside chat can be accessed under “Events & Pr.
Is It Worth Investing in Verastem Inc (NASDAQ: VSTM) Right Now?
Additionally, the 36-month beta value for VSTM is 0.09. There are mixed opinions on the stock, with 3 analysts rating it as a “buy,” 1 rating it as “overweight,” 1 rating it as “hold,” and 0 rating it as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for VSTM is 36.71M and currently, short sellers hold a 6.65% ratio of that float. The average trading volume of VSTM on November 08, 2024 was 707.41K shares.
VSTM’s Market Performance
VSTM’s stock has seen a -0.51% decrease for the week, with a 30.87% rise in the past month and a 68.10% gain in the past quarter. The volatility ratio for the week is 7.30%, and the volatility levels for the past 30 days are at 9.94% for Verastem Inc The simple moving average for the past 20 days is 12.65% for VSTM’s stock, with a -40.93% simple moving average for the past 200 days.
Analysts’ Opinion of VSTM
Many brokerage firms have already submitted their reports for VSTM stocks, with Guggenheim repeating the rating for VSTM by listing it as a “Buy.” The predicted price for VSTM in the upcoming period, according to Guggenheim is $13 based on the research report published on September 30, 2024 of the current year 2024.
BTIG Research, on the other hand, stated in their research note that they expect to see VSTM reach a price target of $27. The rating they have provided for VSTM stocks is “Buy” according to the report published on November 21st, 2023.
B. Riley Securities gave a rating of “Buy” to VSTM, setting the target price at $21 in the report published on September 27th of the previous year.
VSTM Trading at 28.81% from the 50-Day Moving Average
After a stumble in the market that brought VSTM to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -72.57% of loss for the given period.
Volatility was left at 9.94%, however, over the last 30 days, the volatility rate increased by 7.30%, as shares surge +29.46% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +56.30% upper at present.
During the last 5 trading sessions, VSTM fell by -1.91%, which changed the moving average for the period of 200-days by -67.66% in comparison to the 20-day moving average, which settled at $3.46. In addition, Verastem Inc saw -52.09% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at VSTM starting from Paterson Dan, who sale 812 shares at the price of $3.84 back on Nov 05 ’24. After this action, Paterson Dan now owns 231,576 shares of Verastem Inc, valued at $3,118 using the latest closing price.
Calkins Daniel, the Chief Financial Officer of Verastem Inc, sale 6 shares at $2.86 during a trade that took place back on Oct 07 ’24, which means that Calkins Daniel is holding 47,461 shares at $17 based on the most recent closing price.
Stock Fundamentals for VSTM
Current profitability levels for the company are sitting at:
- -11.32 for the present operating margin
- 1.0 for the gross margin
The net margin for Verastem Inc stands at -9.24. The total capital return value is set at -1.29. Equity return is now at value -136.87, with -61.78 for asset returns.
Based on Verastem Inc (VSTM), the company’s capital structure generated 0.79 points at debt to capital in total, while cash flow to debt ratio is standing at -2.65. The debt to equity ratio resting at 3.73. The interest coverage ratio of the stock is -51.12.
Currently, EBITDA for the company is -92.02 million with net debt to EBITDA at 0.63. When we switch over and look at the enterprise to sales, we see a ratio of 8.17. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.23.
Conclusion
In conclusion, Verastem Inc (VSTM) has seen mixed performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
